Viewing Study NCT06959095

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:05 PM
Ignite Modification Date: 2026-01-02 @ 3:21 PM
Study NCT ID: NCT06959095
Status: RECRUITING
Last Update Posted: 2025-10-08
First Post: 2025-04-28
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pulmonary Disease, Chronic Obstructive View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Depemokimab View
None GSK3511294 View
None Eosinophilic phenotype View
None Chronic obstructive pulmonary disease View
None (COPD) View
None Moderate COPD View
None Severe COPD View
None Uncontrolled Moderate to Severe Chronic Obstructive Pulmonary Disease View
None Exacerbations View
None Placebo View
None Type 2 inflammation View